Theravance Biopharma Inc Earnings

The next earnings date for Theravance Biopharma Inc is March 2, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Theravance Biopharma Inc Earnings

Report DateEstimated Earnings Per Share
03/02/2026$0.61

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Theravance Biopharma Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/10/2025---$0100.00%
08/04/2025After Market------
05/12/2025After Market$-0.17-92.67%
02/24/2025After Market$-0.0539.86%
11/12/2024After Market$-0.0674.35%
08/05/2024After Market$-0.28-33.33%
05/13/2024After Market$-0.244.00%
02/26/2024After Market$-0.17-13.33%
11/07/2023After Market$-0.1719.05%
08/07/2023After Market$-0.28-33.33%
05/08/2023After Market$-0.35-34.62%
02/27/2023After Market$-0.1511.76%
11/07/2022After Market$-0.21-16.67%
08/04/2022After Market$-0.09-181.82%
05/05/2022After Market$-0.22-100.00%
02/23/2022After Market$-0.43-30.30%
11/03/2021After Market$-0.4814.29%
08/03/2021After Market$-0.8020.00%
05/04/2021After Market$-1.24-18.10%
02/23/2021After Market$-0.929.80%
11/05/2020After Market$-1.16-19.59%
08/06/2020After Market$-1-2.04%
05/06/2020After Market$-1.40-30.84%
02/24/2020After Market$-1.17-3.54%
11/05/2019After Market$-1.055.41%
07/31/2019Before Market$-0.7241.94%
05/07/2019After Market$-1.32-10.92%
02/26/2019After Market$-0.9213.21%
11/06/2018After Market$-1.104.35%
08/01/2018Before Market$-0.7636.67%
05/08/2018After Market$-1.223.17%
02/27/2018After Market$-1.64-41.38%
11/07/2017After Market$-1.126.67%
08/08/2017After Market$-1.27-11.40%
05/09/2017After Market$-1.27-11.40%
02/27/2017After Market$-1.36-29.52%
11/08/2016After Market$-0.7320.65%
08/08/2016After Market$-1.06-0.95%
05/09/2016After Market$-1.10-14.58%
03/09/2016After Market$-1.2323.60%
11/09/2015After Market$-1.402.78%
08/10/2015After Market$-1.425.96%
05/07/2015After Market$-1.2917.83%
03/10/2015After Market$-2.02-18.82%
11/06/2014After Market$-1.727.03%
08/13/2014---$-1.55-1,650.00%

More About Theravance Biopharma Inc

Website
https://www.theravance.com
Country
USA
Full Time Employees
97

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). Its late-stage investigational once-daily norepinephrine reuptake inhibitor, Ampreloxetine is in the development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.

“Theravance Biopharma Inc Earnings” Can Refer to the Theravance Biopharma Inc Earnings Date

Some people say “Theravance Biopharma Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Theravance Biopharma Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Theravance Biopharma Inc Stock on the Earnings Date

If you own Theravance Biopharma Inc stock (TBPH) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Theravance Biopharma Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Theravance Biopharma Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Theravance Biopharma Inc Earnings

You can contact us any time if you would like to ask questions about Theravance Biopharma Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.